Medtronic plc (MDT)
Data as of , from SEC Form 4 filings.
See up to 3 months of MDT. The 7-day demo opens the 1M and 3M ranges and puts MDT on your watchlist.
Start 7-day demoLatest MDT insider trades
About Medtronic plc (MDT)
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, surgical robots, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
- GALWAY
- 95,000
- 1972
- NYSE
MDT Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 3 | 61,903 | $5.89M |
| Grant or award | 26 | 1,303,933 | |
| Tax withholding / forfeiture | 8 | 29,019 | |
MDT insider transactions (Form 4)
9878 Form 4 filings on record, the earliest from Dec 9, 2024, newest first. Filing history page 2 of 3.
| Traded | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Elizabeth G. Nabel - Director | Grant or award | Ordinary Shares | 2,111 footnote F1 | $0.00 | - | |
| Elizabeth G. Nabel - Director | Tax withholding / forfeiture | Ordinary Shares | 207 footnote F3 | $81.90 | $17K | |
| ||||||
| Grant or award | Ordinary Shares | 2,111 footnote F1 | $0.00 | - | ||
| Tax withholding / forfeiture | Ordinary Shares | 207 footnote F3 | $81.90 | $17K | ||
| ||||||
| Gregory P. Lewis - Director | Grant or award | Ordinary Shares | 2,111 footnote F1 | $0.00 | - | |
| Gregory P. Lewis - Director | Tax withholding / forfeiture | Ordinary Shares | 207 footnote F3 | $81.90 | $17K | |
| ||||||
| Grant or award | Ordinary Shares | 1,803 footnote F1 | $0.00 | - | ||
| ||||||
| William R. Jellison - Director | Grant or award | Ordinary Shares | 1,444 footnote F1 | $0.00 | - | |
| ||||||
| Randall J. Hogan - Director | Grant or award | Ordinary Shares | 2,111 footnote F1 | $0.00 | - | |
| Randall J. Hogan - Director | Tax withholding / forfeiture | Ordinary Shares | 207 footnote F3 | $81.90 | $17K | |
| ||||||
| Grant or award | Ordinary Shares | 1,444 footnote F1 | $0.00 | - | ||
| ||||||
| Lidia Fonseca - Director | Grant or award | Ordinary Shares | 2,111 footnote F1 | $0.00 | - | |
| Lidia Fonseca - Director | Tax withholding / forfeiture | Ordinary Shares | 207 footnote F3 | $81.90 | $17K | |
| ||||||
| Scott C. Donnelly - Director | Grant or award | Ordinary Shares | 2,111 footnote F1 | $0.00 | - | |
| Scott C. Donnelly - Director | Tax withholding / forfeiture | Ordinary Shares | 207 footnote F3 | $81.90 | $17K | |
| ||||||
| Grant or award | Ordinary Shares | 2,111 footnote F1 | $0.00 | - | ||
| Tax withholding / forfeiture | Ordinary Shares | 207 footnote F3 | $81.90 | $17K | ||
| ||||||
| Thierry Pieton - Officer | Tax withholding / forfeiture | Ordinary Shares | 2,976 footnote F1 | $96.71 | $288K | |
| ||||||
| Harry Skip Kiil - Officer | Option exercise | Ordinary Shares | 19,923 | $87.76 | $1.75M | |
| Harry Skip Kiil - Officer | Option exercise | Ordinary Shares | 385 | $80.00 | $31K | |
| Harry Skip Kiil - Officer | Open-market sale | Ordinary Shares | 1,648 | $97.86 | $161K | |
| Harry Skip Kiil - Officer | Open-market sale | Ordinary Shares | 19,255 | $97.77 | $1.88M | |
| Harry Skip Kiil - Officer | Open-market sale | Ordinary Shares | 668 | $97.83 | $65K | |
| Harry Skip Kiil - Officer | Open-market sale | Ordinary Shares | 385 | $97.82 | $38K | |
| Harry Skip Kiil - Officer | Option exercise | Stock Option (Right to Buy) | 30,568 | $0.00 | - | |
| Harry Skip Kiil - Officer | Option exercise | Stock Option (Right to Buy) | 19,923 | $0.00 | - | |
| Harry Skip Kiil - Officer | Option exercise | Stock Option (Right to Buy) | 385 | $0.00 | - | |
| Harry Skip Kiil - Officer | Option exercise | Ordinary Shares | 30,568 | $93.08 | $2.85M | |
| Harry Skip Kiil - Officer | Open-market sale | Ordinary Shares | 30,568 | $97.66 footnote F2 | $2.99M | |
| ||||||
| Denise L. Blomquist - Officer | Gift | Ordinary Shares | 340 | $0.00 | - | |
| Denise L. Blomquist - Officer | Tax withholding / forfeiture | Ordinary Shares | 148 footnote F1 | $101.00 | $15K | |
| ||||||
| Denise L. Blomquist - Officer | Gift | Ordinary Shares | 170 | $0.00 | - | |
| Gregory L. Smith - Officer | Open-market sale | Ordinary Shares | 1,942 | $101.99 | $198K | |
| Gregory L. Smith - Officer | Open-market sale | Ordinary Shares | 1,995 | $102.03 | $204K | |
| Gregory L. Smith - Officer | Open-market sale | Ordinary Shares | 825 | $102.04 | $84K | |
| Gregory L. Smith - Officer | Open-market sale | Ordinary Shares | 227 | $102.05 | $23K | |
| Gregory L. Smith - Officer | Open-market sale | Ordinary Shares | 325 | $102.06 | $33K | |
| Gregory L. Smith - Officer | Open-market sale | Ordinary Shares | 500 | $102.08 | $51K | |
| Gregory L. Smith - Officer | Open-market sale | Ordinary Shares | 24,186 | $101.93 | $2.47M | |
| Harry Skip Kiil - Officer | Open-market sale | Ordinary Shares | 8,405 | $91.58 | $770K | |
| Harry Skip Kiil - Officer | Open-market sale | Ordinary Shares | 200 | $91.59 | $18K | |
| William R. Jellison - Director | Open-market purchase | Ordinary Shares | 2,500 | $92.73 | $232K | |
| William R. Jellison - Director | Open-market purchase | Ordinary Shares | 2,500 | $92.37 | $231K | |
| Michael Marinaro - Officer | Tax withholding / forfeiture | Ordinary Shares | 1,052 | $93.22 | $98K | |
| Option exercise | Ordinary Shares | 2,179 | $0.00 | - | ||
| Tax withholding / forfeiture | Ordinary Shares | 667 | $89.34 | $60K | ||
| Tax withholding / forfeiture | Ordinary Shares | 364 | $89.34 | $33K | ||
| Option exercise | Ordinary Shares | 963 | $78.00 | $75K | ||
| Tax withholding / forfeiture | Ordinary Shares | 879 | $89.34 | $79K | ||
| Option exercise | Performance Share Unit | 2,179 | $0.00 | - | ||
| Option exercise | Stock Option (Right to Buy) | 963 | $0.00 | - | ||
| Michael Marinaro - Officer | Option exercise | Ordinary Shares | 6,535 | $0.00 | - | |
| Michael Marinaro - Officer | Tax withholding / forfeiture | Ordinary Shares | 3,158 | $89.34 | $282K | |
| Michael Marinaro - Officer | Tax withholding / forfeiture | Ordinary Shares | 1,741 | $89.34 | $156K | |
| Michael Marinaro - Officer | Option exercise | Ordinary Shares | 3,126 | $78.00 | $244K | |
| Michael Marinaro - Officer | Tax withholding / forfeiture | Ordinary Shares | 2,864 | $89.34 | $256K | |
| Michael Marinaro - Officer | Option exercise | Performance Share Unit | 6,535 | $0.00 | - | |
| Michael Marinaro - Officer | Option exercise | Stock Option (Right to Buy) | 3,126 | $0.00 | - | |
| Harry Skip Kiil - Officer | Option exercise | Ordinary Shares | 10,457 | $0.00 | - | |
| Harry Skip Kiil - Officer | Tax withholding / forfeiture | Ordinary Shares | 4,659 | $89.34 | $416K | |
| Harry Skip Kiil - Officer | Tax withholding / forfeiture | Ordinary Shares | 2,896 | $89.34 | $259K | |
| Harry Skip Kiil - Officer | Option exercise | Performance Share Unit | 10,457 | $0.00 | - | |
| Denise L. Blomquist - Officer | Option exercise | Ordinary Shares | 246 | $0.00 | - | |
| Denise L. Blomquist - Officer | Tax withholding / forfeiture | Ordinary Shares | 93 | $89.34 | $8K | |
| Denise L. Blomquist - Officer | Option exercise | Ordinary Shares | 58 | $0.00 | - | |
| Denise L. Blomquist - Officer | Tax withholding / forfeiture | Ordinary Shares | 22 | $89.34 | $2K | |
| Denise L. Blomquist - Officer | Tax withholding / forfeiture | Ordinary Shares | 204 | $89.34 | $18K | |
| Denise L. Blomquist - Officer | Option exercise | Ordinary Shares | 214 | $78.00 | $17K | |
| Denise L. Blomquist - Officer | Tax withholding / forfeiture | Ordinary Shares | 196 | $89.34 | $18K | |
| Denise L. Blomquist - Officer | Option exercise | Performance Share Unit | 246 | $0.00 | - | |
| Denise L. Blomquist - Officer | Option exercise | Performance Share Unit | 58 | $0.00 | - | |
| Denise L. Blomquist - Officer | Option exercise | Stock Option (Right to Buy) | 214 | $0.00 | - | |
| Option exercise | Ordinary Shares | 57,724 | $0.00 | - | ||
| Tax withholding / forfeiture | Ordinary Shares | 26,323 | $89.34 | $2.35M | ||
| Tax withholding / forfeiture | Ordinary Shares | 13,054 | $89.34 | $1.17M | ||
| Option exercise | Ordinary Shares | 40,600 | $78.00 | $3.17M | ||
| Tax withholding / forfeiture | Ordinary Shares | 37,798 | $89.34 | $3.38M | ||
| Option exercise | Performance Share Units | 57,724 | $0.00 | - | ||
| Option exercise | Stock Option (Right to Buy) | 40,600 | $0.00 | - | ||
| Gregory L. Smith - Officer | Option exercise | Ordinary Shares | 11,328 | $0.00 | - | |
| Gregory L. Smith - Officer | Tax withholding / forfeiture | Ordinary Shares | 4,458 | $89.34 | $398K | |
| Gregory L. Smith - Officer | Tax withholding / forfeiture | Ordinary Shares | 2,656 | $89.34 | $237K | |
| Gregory L. Smith - Officer | Option exercise | Performance Share Units | 11,328 | $0.00 | - | |
| Brett A. Wall - Officer | Option exercise | Ordinary Shares | 15,249 | $0.00 | - | |
| Brett A. Wall - Officer | Tax withholding / forfeiture | Ordinary Shares | 7,744 | $89.34 | $692K | |
| Brett A. Wall - Officer | Tax withholding / forfeiture | Ordinary Shares | 3,850 | $89.34 | $344K | |
| Brett A. Wall - Officer | Option exercise | Performance Share Units | 15,249 | $0.00 | - | |
| Gregory L. Smith - Officer | Tax withholding / forfeiture | Ordinary Shares | 1,630 | $90.24 | $147K | |
| Grant or award | Ordinary Shares | 4,350 | $0.00 | - | ||
| Grant or award | Performance Share Units | 10,874 | $0.00 | - | ||
| Grant or award | Stock Option (Right to Buy) | 30,669 | $0.00 | - | ||
| Grant or award | Ordinary Shares | 5,437 | $0.00 | - | ||
| Grant or award | Ordinary Shares | 16,310 | $0.00 | - | ||
| Grant or award | Performance Share Units | 13,592 | $0.00 | - | ||
| Grant or award | Stock Option (Right to Buy) | 38,336 | $0.00 | - | ||
| Thierry Pieton - Officer | Grant or award | Ordinary Shares | 8,699 | $0.00 | - | |
| Thierry Pieton - Officer | Grant or award | Performance Share Units | 21,747 | $0.00 | - | |
| Thierry Pieton - Officer | Grant or award | Stock Option (Right to Buy) | 61,338 | $0.00 | - | |
Recent MDT Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Michael Marinaro | Officer | 10,420 | $1.00M | View on EDGAR | |
| Geoffrey Martha | Officer, Director | 50,000 |
Stock trades in MDT disclosed by members of the U.S. House in the last 12 months, newest first. Values are the ranges as filed.
| Member | Type | Traded | Disclosed | Value range | Owner | Days to disclose | Filing |
|---|---|---|---|---|---|---|---|
| Sale |
MDT insider trading FAQ
What is the latest insider trade for MDT?
Medtronic plc (MDT) had 15 insider filings in the last 90 days, with the most recent on 21 October 2026. The full record for MDT runs to 78 Form 4 filings, the earliest from 9 December 2024. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying MDT stock?
No insider purchases of MDT were filed in the last 90 days. 2 purchases are on record for this company.
How many insiders are selling MDT stock?
3 insider sales of MDT were filed in the last 90 days, totaling $5.89M.
Where can I see MDT SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects MDT Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Kevin E. Lofton view on EDGAR
- - Michael Marinaro view on EDGAR
- - Geoffrey Martha view on EDGAR
- - Harry Skip Kiil view on EDGAR
- - Denise L. Blomquist view on EDGAR
- - Michael Marinaro view on EDGAR
- - Denise L. Blomquist view on EDGAR
- - Matthew R. Walter view on EDGAR
- - Kweli Thompson view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where MDT's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow MDT with a 7-day demo
- MDT on your watchlist
- Every MDT Form 4 filing on record
- Up to 3 months of MDT price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive